Organization Overview
Historical Acquisition Tree
Alternative names
Key: Exeltis (30) Acquired (1)
acetaminophen (tylenol) (2016)
aciclovir (zovirax) (2020)
benznidazole (Rochagan) (2017 NDA)
betamethasone (celestone) (2023)
clobetasol (dermovate) (2018)
cyanocobalamin (berocca) (2021)
darifenacin (enablex) (2019)
desogestrel (Mercilon) (2015)
drospirenone (Yasmin) (2019)
ephedrine (2022)
estradiol (progynon depot) (2003)
ethinyl estradiol (Estinyl) (2020)
fluocinonide (lidex) (2019)
fosfomycin (monurol) (2020)
fulvestrant (faslodex) (2021)
glycopyrronium (robinul) (2021)
hydrocodone (hycodan) (2020)
ketoconazole (nizoral) (2021)
lansoprazole (prevacid) (2016)
metronidazole (flagyl) (2014)
midodrine (proamatine) (2020)
naftifine (naftin) (2020)
nitroprusside (nipride) (2020)
norethindrone (2018)
norgestimate (2013)
norgestrel (Ovral) (2020)
omeprazole (prilosec) (2020)
oxycodone (oxycontin) (2016)
progesterone (progestasert) (2017)
ramelteon (rozerem) (2022)
testosterone (delatestryl) (2020)
Key: Exeltis (6) Acquired (1)
Key: Exeltis (0) Acquired (1)
Candidiasis, Vulvovaginal (Phase 4)
Chagas Disease (Phase 3)
Diarrhea (Phase 3)
Hemolysis (Phase 3)
Hemolytic-Uremic Syndrome (Phase 3)
Infections (Phase 4)
Kidney Diseases (Phase 3)
Syndrome (Phase 3)
Trichomonas Vaginitis (Phase 4)
Vaginal Diseases (Phase 4)
Vaginitis (Phase 4)
Vaginosis, Bacterial (Phase 4)
Vulvovaginitis (Phase 4)